Pregabalin and Lacosamide for Post-Herpetic Neuralgia in Herpes Zoster Patients
Pregabalin
+ Lacosamide
Varicella Zoster Virus Infection+12
+ DNA Virus Infections
+ Herpes Zoster
Treatment Study
Summary
Study start date: April 10, 2025
Actual date on which the first participant was enrolled.Post-herpetic neuralgia (PHN) is a painful condition that arises after shingles, a viral infection caused by the reactivation of the chickenpox virus. This pain can last long after the rash clears up and is particularly burdensome for older adults and those with weakened immune systems. It can disrupt sleep and daily activities due to its chronic and sometimes severe nature. This study focuses on comparing two medications, Pregabalin and Lacosamide, both known to alleviate neuropathic pain, to determine which is more effective in treating PHN. The insights gained could help improve treatment choices for those suffering from this challenging condition. Participants in the study receive either Pregabalin or Lacosamide to manage their PHN symptoms. The study evaluates how well each medication reduces pain and improves the quality of life for patients. By comparing these two treatments, researchers hope to identify the most effective option, helping doctors make informed decisions about managing PHN. The study does not specify any particular risks or benefits, focusing instead on understanding the relative effectiveness of the two drugs.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location